NT_1170x120_1-11-18

Mucinex D

Allergan, Perrigo launch store-brand Mucinex D

Allergan, Perrigo launch store-brand Mucinex D

DUBLIN, Ireland — Allergan plc and Perrigo Co. plc have launched combination guaifenesin 600-mg and pseudoephedrine HCl 60-mg extended-release tablets to retail and wholesale customers. Allergan and Perrigo said Monday that the initial shipments of the new store-brand product, which began in December, mark a first-to-market achievement for the companies. “This first-to-market launch illustrates the

Actavis, Perrigo to release store-brand Mucinex D

DUBLIN, Ireland — Actavis plc and Perrigo Co. plc have been cleared by the Food and Drug Administration to market guaifenesin/pseudoephedrine tablets, an expectorant. The companies said Tuesday that Perrigo is slated to commence shipments to U.S. retail and wholesale customers in time for the cough/cold season. The product will be packaged and marketed under